(Q80155644)

English

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

scientific article published on 20 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

James W Huleatt

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Valerian Nakaar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Priyanka Desai

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yan Huang

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Duane Hewitt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Andrea Jacobs

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jie Tang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William McDonald

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Langzhou Song

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Robert K Evans

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Scott Umlauf

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lynda Tussey

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T J Powell

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

20 November 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

201-214

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Characterization of the 1918 "Spanish" influenza virus matrix gene segment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

A "universal" human influenza A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Universal influenza A vaccine: optimization of M2-based constructs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Influenza virus uncoating in infected cells and effect of rimantadine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

The molecular basis of the specific anti-influenza action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Protection against influenza virus challenge by topical application of influenza DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Approaching the asymptote? Evolution and revolution in immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Innate immune induction of the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Immunostimulatory DNA is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Regulation of phagosome maturation by signals from toll-like receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Modified M2 proteins produce heterotypic immunity against influenza A virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of Escherichia coli lipopolysaccharide on histamine-forming capacity and antibody formation in lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.062

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.10.062

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063235%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80155644&oldid=1531256858"